Evidence map›Paper›PMID 42315922›Full record

ArticleNature biotechnology2026

Publisher Correction: Lung and liver editing by lipid nanoparticle delivery of a stable CRISPR-Cas9 ribonucleoprotein.

Kai Chen, Hesong Han, Sheng Zhao, Bryant Xu, Boyan Yin, Atip Lawanprasert, Marena Trinidad, Benjamin W Burgstone, Niren Murthy, Jennifer A Doudna

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Kai Chen *Department of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-3325-3536
Hesong Han *Innovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.
Sheng ZhaoInnovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0009-0002-9890-048X
Bryant XuDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0009-0000-2464-6111
Boyan YinInnovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.
Atip LawanprasertInnovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0009-0001-3163-8803
Marena TrinidadDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA.
Benjamin W BurgstoneInnovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0009-0000-8256-3867
Niren MurthyInnovative Genomics Institute, University of California Berkeley, Berkeley, CA, USA. nmurthy@berkeley.edu.ORCID http://orcid.org/0000-0002-7815-7337
Jennifer A DoudnaDepartment of Molecular and Cell Biology, University of California Berkeley, Berkeley, CA, USA. doudna@berkeley.edu.ORCID http://orcid.org/0000-0001-9161-999X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42315922
PMCPMC13368578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.